The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for HCV Trial01/01/2019 - 12/31/2022 (Subcontract PI)
Denver Health Medical Center NIH NIDA5R01DA042982-03
IMPROVING NALOXONE ACCESS AND ITS EFFECTS ON DRUG ABUSE AND OVERDOSES02/25/2019 - 09/29/2021 (Subcontract PI)
RAND Corporation HHS CDC5R01CE002999-02
Expanding FDA's Opioids Systems Model to Enable Economic Evaluations and Outcome Analyses of National Opioid Policies09/01/2020 - 08/31/2021 (Subcontract PI)
General Hospital Corp d/b/a Massachusetts General Hospital HHS FDA1U01FD007064-01
Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Evaluating Intervention Outcomes for Individuals, Systems, and Communities07/15/2020 - 04/30/2021 (Subcontract PI)
Weill Medical College of Cornell University NIH NIDA2P30DA040500-06A1
Researching Effective Strategies to Prevent Opioid Death (RESPOND)04/01/2019 - 03/31/2021 (Subcontract PI)
Boston Medical Center Corporation NIH NIDA5R01DA046527-03
Impact of health insurance type and transitions on treatment for opioid use disorder04/01/2019 - 03/31/2021 (Subcontract PI)
Boston Medical Center Corporation Robert Wood Johnson
Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND)05/15/2019 - 02/28/2021 (Subcontract PI)
Weill Medical College of Cornell NIH NIDA5U01DA047408-02
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (CHERISH Supplement)05/01/2019 - 07/15/2020 (Subcontract PI)
Weill Medical College of Cornell NIH NIDA3P30DA040500-05S1
WHO Level of Detection04/01/2019 - 06/30/2020 (Subcontract PI)
FIND Foundation World Health Org
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (CHERISH)05/01/2019 - 04/30/2020 (Subcontract PI)
Weill Medical College of Cornell University NIH NIDA5P30DA040500-05